HSBC Holdings’s iRadimed IRMD Stock Holding History

HSBC Holdings’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.47M	Sell	15,357 -6,202	-29%	-$620K	﹤0.01%	1670
2025 Q4	$2.1M	Buy	21,559 +3,468	+19%	+$298K	﹤0.01%	1549
2025 Q3	$1.27M	Buy	18,091 +3,670	+25%	+$245K	﹤0.01%	1699
2025 Q2	$865K	Buy	14,421 +2,509	+21%	+$138K	﹤0.01%	1867
2025 Q1	$614K	Buy	11,912 +392	+3%	+$22K	﹤0.01%	1983
2024 Q4	$637K	Buy	11,520 +740	+7%	+$38.9K	﹤0.01%	2036
2024 Q3	$539K	Buy	10,780 +1,436	+15%	+$66.3K	﹤0.01%	1976
2024 Q2	$410K	Buy	9,344 +1,195	+15%	+$50.8K	﹤0.01%	2089
2024 Q1	$358K	Buy	8,149 +818	+11%	+$36.2K	﹤0.01%	2309
2023 Q4	$343K	Buy	7,331 +1,651	+29%	+$69.4K	﹤0.01%	2222
2023 Q3	$251K	Buy	+5,680	New	+$264K	﹤0.01%	2301
2021 Q1	–	Sell	-9,579	Closed	-$224K	–	2930
2020 Q4	$224K	Buy	9,579 +147	+2%	+$3.4K	﹤0.01%	2742
2020 Q3	$205K	Hold	9,432	–	–	﹤0.01%	2458
2020 Q2	$219K	Buy	+9,432	New	+$202K	﹤0.01%	2308

Other funds holding IRMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HSBC Holdings's IRMD Position: Q1 2026 in Review

HSBC Holdings reduced its iRadimed (IRMD) stake by 29% in Q1 2026, selling an estimated $620K and leaving 15,357 shares worth $1.47M. The position accounts for ﹤0.01% of the portfolio, ranked #1670.

HSBC Holdings first reported a position in IRMD in Q2 2020 and has held it in 14 quarters since. The position peaked at $2.1M in Q4 2025. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

HSBC Holdings held 15,357 shares of iRadimed worth $1.47M as of Q1 2026.
HSBC Holdings sold 6,202 iRadimed shares in Q1 2026, an estimated $620K.
iRadimed made up ﹤0.01% of HSBC Holdings's portfolio in Q1 2026, its #1670 holding.
HSBC Holdings first reported a position in iRadimed in Q2 2020 and has held it in 14 quarters since.
HSBC Holdings's iRadimed position peaked at $2.1M in Q4 2025.
228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.